We are live on ! Find out more
Adage Capital Partners

Adage Capital Partners Portfolio holdings

AUM $64.8B
1-Year Est. Return 42.7%
This Fund
S&P 500
This Quarter Est. Return
-1.78%
1 Year Est. Return
+42.7%
3 Year Est. Return
+139.29%
5 Year Est. Return
+204.38%
10 Year Est. Return
+879.75%
AUM
$54B
AUM Growth
-$3.2B
Cap. Flow
-$865M
Cap. Flow %
-1.6%
Top 10 Hldgs %
28.71%
Holding
986
New
116
Increased
314
Reduced
359
Closed
149

Top Buys

Rank Stock Value
1
HUBB icon
Hubbell
HUBB
+$244M
2
NSC icon
Norfolk Southern
NSC
+$149M
3
INSM icon
Insmed
INSM
+$138M
4
VRTX icon
Vertex Pharmaceuticals
VRTX
+$131M
5
DHR icon
Danaher
DHR
+$119M

Top Sells

Rank Stock Value
1
RPRX icon
Royalty Pharma
RPRX
+$340M
2
BMY icon
Bristol-Myers Squibb
BMY
+$339M
3
UNP icon
Union Pacific
UNP
+$191M
4
MCD icon
McDonald's
MCD
+$190M
5
HES
Hess
HES
+$168M

Sector Composition

Rank Sector Weight
1 Technology 26.3%
2 Healthcare 14.99%
3 Financials 12.56%
4 Consumer Discretionary 9.54%
5 Industrials 8.62%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
EOLS icon
676
Evolus
EOLS
$489M
$5.85M 0.01%
+486,400
New +$6.36M
OLLI icon
677
Ollie's Bargain Outlet
OLLI
$4.71B
$5.82M 0.01%
+50,000
New +$5.29M
WSM icon
678
Williams-Sonoma
WSM
$29.1B
$5.77M 0.01%
+36,475
New +$7.05M
BF.B icon
679
Brown-Forman Class B
BF.B
$13B
$5.64M 0.01%
166,232
-3,900
-2% -$131K
PCTY icon
680
Paylocity
PCTY
$8.04B
$5.62M 0.01%
30,000
-20,000
-40% -$4M
AXSM icon
681
Axsome Therapeutics
AXSM
$10.8B
$5.6M 0.01%
48,000
-12,000
-20% -$1.37M
HRMY icon
682
Harmony Biosciences
HRMY
$2.26B
$5.58M 0.01%
168,000
-332,000
-66% -$11.9M
RMD icon
683
ResMed
RMD
$32.4B
$5.52M 0.01%
24,663
-21,876
-47% -$5.11M
ABUS icon
684
Arbutus Biopharma
ABUS
$897M
$5.5M 0.01%
1,575,941
-75,000
-5% -$250K
CMI icon
685
Cummins
CMI
$88.7B
$5.42M 0.01%
17,287
-110,879
-87% -$39.1M
LKQ icon
686
LKQ Corp
LKQ
$6.19B
$5.42M 0.01%
127,300
-115,600
-48% -$4.58M
KNF icon
687
Knife River
KNF
$3.83B
$5.41M 0.01%
+60,000
New +$5.85M
ERIE icon
688
Erie Indemnity
ERIE
$13.3B
$5.36M 0.01%
12,800
-500
-4% -$204K
CUBE icon
689
CubeSmart
CUBE
$9.42B
$5.34M 0.01%
125,000
+25,000
+25% +$1.04M
CNM icon
690
Core & Main
CNM
$8.52B
$5.31M 0.01%
+110,000
New +$5.7M
MKTX icon
691
MarketAxess Holdings
MKTX
$5.72B
$5.29M 0.01%
24,450
+11,200
+85% +$2.35M
IMNM icon
692
Immunome
IMNM
$2.92B
$5.22M 0.01%
775,000
+275,000
+55% +$2.64M
YUM icon
693
Yum! Brands
YUM
$41.6B
$5.12M 0.01%
+32,552
New +$4.69M
PHM icon
694
Pultegroup
PHM
$24.7B
$5.12M 0.01%
49,800
-11,800
-19% -$1.27M
UDR icon
695
UDR
UDR
$12.3B
$5.11M 0.01%
113,026
-127,474
-53% -$5.46M
CABA icon
696
Cabaletta Bio
CABA
$450M
$5.03M 0.01%
3,634,473
RF icon
697
Regions Financial
RF
$26.8B
$4.99M 0.01%
229,600
-119,600
-34% -$2.79M
ACHR icon
698
Archer Aviation
ACHR
$3.99B
$4.98M 0.01%
+700,000
New +$6.21M
IE icon
699
Ivanhoe Electric
IE
$1.69B
$4.92M 0.01%
845,978
+73,088
+9% +$463K
AVTR icon
700
Avantor
AVTR
$8.91B
$4.86M 0.01%
+300,000
New +$5.68M

Similar funds

Adage Capital Partners's Q1 2025 Portfolio in Review

As of Q1 2025, Adage Capital Partners held 986 positions worth $54B, down 5.6% from $57.2B the previous quarter. Its ten largest holdings account for 29% of the portfolio.

Adage Capital Partners's Q1 2025 filing shows 116 new, 314 increased, 359 reduced and 149 closed positions. Its largest new stake was Diamondback Energy: 485,503 shares worth $77.6M. The largest sale was Royalty Pharma, an estimated $340M.

By sector, the portfolio is most concentrated in Technology at 26% of assets, down from 29% a quarter earlier, followed by Healthcare and Financials.

  • Adage Capital Partners's largest Q1 2025 buy was Diamondback Energy: 485,503 shares worth $77.6M.
  • Adage Capital Partners added most to Hubbell in Q1 2025, an estimated $244M increase.
  • Adage Capital Partners's biggest Q1 2025 reduction was Royalty Pharma, cutting an estimated $340M.
  • Adage Capital Partners fully exited Geron in Q1 2025, selling an estimated $77.2M.
  • Adage Capital Partners's ten largest holdings make up 29% of its $54B portfolio in Q1 2025.
  • Adage Capital Partners opened 116 new positions and closed 149 in Q1 2025.
  • Adage Capital Partners's portfolio value fell 5.6% quarter-over-quarter to $54B.

Based on Adage Capital Partners's 13F filing for Q1 2025, filed 15 May 2025.